-
August 15: The Week in Cancer News
Some women over 70 may not need chemotherapy for high-risk breast cancer, and an early trial finds a pancreatic cancer vaccine can trigger an immune response.
by Marci A. Landsmann
-
August 8: The Week in Cancer News
A targeted therapy offers new treatment for a deadly brain cancer that mainly affects children, and more people in their 40s are getting screened for colorectal cancer.
by Marci A. Landsmann
-
August 1: The Week in Cancer News
Most liver cancers can be prevented, and a common type of HPV is linked to skin cancer.
by Eric Fitzsimmons
-
July 25: The Week in Cancer News
Doctors often don’t discuss sexual side effects with breast cancer survivors, and cardiac biomarkers may indicate increased risk for certain cancers.
by Thomas Celona
-
July 18: The Week in Cancer News
Less than half of people with advanced cancer undergo genomic profiling, and gastrointestinal cancer rates are rising dramatically in younger adults.
by Marci A. Landsmann
-
July 11: The Week in Cancer News
Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.
by Eric Fitzsimmons
-
July 3: The Week in Cancer News
Uterine cancer diagnoses expected to climb in the next 25 years, and some disposable e-cigarettes emit more carcinogens than traditional cigarettes.
by Thomas Celona
-
June 27: The Week in Cancer News
Low-dose aspirin reduces cancer risk for people with Lynch syndrome, and breast cancer survivors may have lower risk for Alzheimer’s than the general public.
by Thomas Celona
-
June 20: The Week in Cancer News
Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.
by Eric Fitzsimmons
-
June 13: The Week in Cancer News
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
by Marci A. Landsmann
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona